4th quarter and preliminary year end financials for 2013 for Medistim ASA
4th quarter and preliminary year end financials for 2013 for Medistim ASA
Medistim delivers record sales for a quarter with
MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK
191 (MNOK 183.8), which is a 3.9 % growth. Operating
profit (EBIT) for the quarter ended at MNOK 9.0 (MNOK
6.1). Operating profit for 2013 ended at MNOK 35.6
(MNOK 41.1). The Board suggests a dividend of NOK
0.80 per share (MNOK 1.10).